Articles with public access mandates - Stas VolikLearn more
Available somewhere: 34
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate CancerAR Gene Aberrations in Circulating …
AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ...
Clinical cancer research 21 (10), 2315-2324, 2015
Mandates: National Health and Medical Research Council, Australia, Canadian Institutes …
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug DevelopmentNext-Generation Models of Prostate Cancer
D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ...
Cancer research 74 (4), 1272-1283, 2014
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies
S Volik, M Alcaide, RD Morin, C Collins
Molecular Cancer Research 14 (10), 898-908, 2016
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Widespread and functional RNA circularization in localized prostate cancer
S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ...
Cell 176 (4), 831-843. e22, 2019
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research, Natural …
Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer
AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ...
JAMA oncology 2 (12), 1598-1606, 2016
Mandates: US National Institutes of Health, National Health and Medical Research …
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
N Lallous, SV Volik, S Awrey, E Leblanc, R Tse, J Murillo, K Singh, ...
Genome biology 17 (1), 1-15, 2016
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
The proteogenomic landscape of curable prostate cancer
A Sinha, V Huang, J Livingstone, J Wang, NS Fox, N Kurganovs, ...
Cancer Cell 35 (3), 414-427. e6, 2019
Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ...
The Journal of pathology 227 (3), 286-297, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Whole-genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression
S Ren, GH Wei, D Liu, L Wang, Y Hou, S Zhu, L Peng, Q Zhang, Y Cheng, ...
European urology 73 (3), 322-339, 2018
Mandates: National Natural Science Foundation of China, Academy of Finland
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerctDNA Alterations in Metastatic Bladder Cancer
G Vandekerkhove, T Todenhöfer, M Annala, WJ Struss, A Wong, K Beja, ...
Clinical Cancer Research 23 (21), 6487-6497, 2017
Mandates: Academy of Finland
Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer
A Bashir, S Volik, C Collins, V Bafna, BJ Raphael
PLoS computational biology 4 (4), e1000051, 2008
Mandates: US National Institutes of Health
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ...
Genome medicine 11 (1), 1-12, 2019
Mandates: Canadian Institutes of Health Research
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
Y Feng, VR Ramnarine, R Bell, S Volik, E Davicioni, VM Hayes, S Ren, ...
BMC genomics 20 (1), 1-8, 2019
Mandates: Prostate Cancer Canada, National Natural Science Foundation of China
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ...
Genome biology 15 (8), 1-14, 2014
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Stromal gene expression is predictive for metastatic primary prostate cancer
F Mo, D Lin, M Takhar, VR Ramnarine, X Dong, RH Bell, SV Volik, ...
European urology 73 (4), 524-532, 2018
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
C Wu, AW Wyatt, AV Lapuk, A McPherson, BJ McConeghy, RH Bell, ...
The Journal of pathology 227 (1), 53-61, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
VR Ramnarine, M Alshalalfa, F Mo, N Nabavi, N Erho, M Takhar, ...
GigaScience 7 (6), giy050, 2018
Mandates: Prostate Cancer Canada
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA
C Kockan, F Hach, I Sarrafi, RH Bell, B McConeghy, K Beja, A Haegert, ...
Bioinformatics 33 (1), 26-34, 2017
Mandates: Canadian Cancer Society, Genome Canada, Natural Sciences and Engineering …
Poly‐gene fusion transcripts and chromothripsis in prostate cancer
C Wu, AW Wyatt, A McPherson, D Lin, BJ McConeghy, F Mo, R Shukin, ...
Genes, Chromosomes and Cancer 51 (12), 1144-1153, 2012
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Comrad: detection of expressed rearrangements by integrated analysis of RNA-Seq and low coverage genome sequence data
A McPherson, C Wu, I Hajirasouliha, F Hormozdiari, F Hach, A Lapuk, ...
Bioinformatics 27 (11), 1481-1488, 2011
Mandates: Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program